| Table 5: | ||||
|
Pharmacologic
Agents for the Treatment of Asthma
|
||||
|
Generic
Name |
Brand
Name
(Manufacturer) |
Delivery
Route/
Device |
Suggested
Dosage
(Adults) |
Comment
|
| Anticholinergics | ||||
| Atropine
sulfate |
Many | Solution 0.2% (1 mg/0.5 mL) 0.5% (2.5 mg/0.5 mL) (1.25 mg) |
0.025 mg/kg diluted with 3-5 mL NS q 6-8 hr | Minimal side effects with ipratropium; |
| Ipratropium
bromide |
Atrovent
(Boehringer) |
MDI (18 g/puff) Solution 0.02% (500-µ g unit dose vial) |
2-4
puffs qid; max = 12 puffs/day 500 µg/tid, qid |
Approved for COPD only |
| Tiotropium | Spiriva (Boehringer) | DPI 8 mg/puff | 1 puff per day | Approved for COPD only |
| β2-Adrenergic Agents | ||||
| Albuterol sulfate | Airet
(Medeva) Albuterol (various generic) Proventil (Schering) |
Solution (0.83%)
Tablets (2,4 mg) |
2.5-10 mg q 6-8 hr 2.5-10 mg a 6-8 hr
2-4 mg q 6-8 hr; max:
32 mg/day |
Inaled
agents have fewer systemic side effects; β-2 selective agents are albuterol, bitolterol, metaproterenol, pirbuterol, almeterol, terbutaline |
| Proventil-HFA (Schering) | MDI
(90 µg/puff) Repetabs (sustained Release tablets), 4 mg |
2-4
puffs q 4-6 hr 4 mg q 12 hr |
||
| Ventolin (Glaxo) |
MDI (90 µg/puff) Rotohaler (200 µg/ |
Max:
16-30 puffs/day (200 puffs) 200-400 µg q 6-8 hr; max dose=2.4 mg/day 2.5-10 mg q 6-8 hr |
||
| Volmax (Muro) | Sustained-release tablets (4, 8 mg) | 4-8 mg q 12 hr | ||
| Bitolterol mesylate | Tornalate (Sanofi Winthrop) | MDI (370 µg/puff) | 2 puffs q 6 hr | |
| Epinephrine | Medihaler-Epi (3M Pharm) Many |
MDI (300 µg/puff) |
2 puffs qid | |
| Adrenalin
chloride (Parke-Davis) |
SC inection 1:1000 (1 mg/mL) | 0.2-0.5 mg SC (0.2-0.5 mL SC) q 20 min | ||
| Formoterol | Foradil
(Novartis) (investigational in USA) |
MDI DPI |
||
| Isoetharine HCl | Bronkometer (Sanofi Winthrop) Many |
MDI (340 µg/puff) Solutions for inhalation |
1-2 puffs q 4 hr 0.25-1 mL nebulized with NS |
|
| Isoproterenol HCL | Medihaler-150
(3M Pharm) Isuprel Mistometer (Sanofi Winthrop) |
MDI (800 µg/puff) MDI (131 µg/puff) Solution (0.5%, 1%,
5%) |
1-2 puff qid 1-2 puffs qid |
|
| Levalbuterol | Xopenex (Sepracor) | Solution for nebulizer (0.63 mg) | 0.63 mg q 6-8 hr | |
| Metaproterenol | Alupent (Boehringer) |
MDI (650 µg/puff)
|
2-3 puffs q 3-4 hr max=12 puff/day 0.3 mL in 2.5 mL NS q 4-6 hr 10 mg q 6-8 hr, 10 mg up to 20 mg |
|
| Metaprel (Sandoz) |
MDI (650 µg/puff)
|
2-3 puffs q 3-4 hr; max=12 0.3 mL in 2.5 mL NS q 4-6 hr 10 mg q 6-8 hr, up to 20 mg |
||
| Pirbuterol acetate | Maxair (3M Pharm) |
MDI (200 µg/puff)
|
1-2 puffs q 4-6 hr; max=12 puffs/day 2 puffs q 6 hr |
|
| Salmeterol | Serevent (Glaxo) | MDI
(46 µg/puff) Diskus (DPI 50 µg/puff) |
2 puffs q 12 hr | |
| Terbutaline sulfate | Brethaire (Geigy) |
MDI (200 µg/puff)
|
1-2 puffs q 4-6 hr 2.5-5 mg tid; max=15 mg/24 hr |
|
| Bricanyl (Marion Merrell Dow) |
MDI
(200 µg/puff) Tablets (2.5, 5 mg) |
1-2
puffs q 4-6 hr 2.4-5 mg tid max=15 mg/24 hr |
||
| Cromoglycates | ||||
| Cromolyn sodium | Intal (Fisons) | Spinhaler
(20 mg capsules) MDI (800 µg/puffs) Solution (20 mg/2 ml ampule) |
20 mg qid |
Contraindication in acute asthma |
| Inhaled corticosteroids | ||||
| Nedocromil
sodium Beclomethasone dipropionate |
Tilade
(Aventis) Beclovent (Allen & Hanburys) |
MDI
(1.75 mg/puff) MDI (42 µg/puff) |
2
puffs bid, tid, qid 2 puffs tid-qid: max=20 puffs/day |
Need more than 400 µg/day to maintain off oral steroids, no adrenal suppression if <800-1200 µg/day |
|
HFA-BDP Vanceril DS |
MDI (40 or 80 µg/puff) |
2-8
puffs bid 2 puffs tid-qid; max=20 puffs/day 2 puffs tid-qid; max=20 puffs/day |
||
| Budesonide |
Pulmicort |
Turbuhaler (200 µg/puff) |
400-1600 µg
in divided doses bid-qid |
Approved for 12 mos-8 yrs; only approved |
| Flunisolide | AeroBid (Forest) | MDI (250 µg/puff) | 2 puffs bid; max=8 puffs/day | |
| Fluticasone propionate | Flovent (Glaxo) | MDI
(44, 110, 220, µg/puff) Diskus powder inhaler (50, 100, 250 µg/puff) |
100-800 µg/day | |
|
Mometasone furoate Triamcinolone acetonide |
Asthmanex Azmacort (Rhone-Poulenc Rorter) |
N/A MDI (100 µg/puff) |
N/A 2-4 puffs qid; max=16 puffs/day |
|
| Combination Products | ||||
|
Albuterol/ Salmeterol/flutcasone Fomoterol/budesonide |
Combivent Advair (Glaxo)
|
MDI (18 µg/ipratropium/ Diskus (DPI)
|
2 puffs qid 50/100, 50/250, 50/500 N/A |
|
| Antileukotrienes | ||||
|
Montelukast Zileuton |
Singulair (Merck) Zyflo (Abbott) |
Tablet (5, 10 mg) Tablets (600 mg) |
10 mg qd in the evening 600 mg qid |
Churg-Strauss |
| Methylxanthines | ||||
| Aminophylline | Various | IV | Load: If not on theophylline at home, 5-6 mg/kg over 20 min; if on theophylline, level pending, 3 mg/kg over 20 min; a bolus of 0.5 mg/kg will increase level by 2 in the average adult. Maintenacne 0.5-0.9 mg/kg/hr; 200-400 mg bid | Decreased clearance with cirrhosis, CHF, erythromycin, cimetidine, troleadomycin increased clearance with smoking, young age, and phenobarbital. Need to follow serum levels |
| Anti-IgE | ||||
| Omalizumab | Xolar (Genentech/Novartis) |
Subcutaneous | 0.016 mg X body wt (kg) X IgE level (IU/ml); also see nomogram | See text for details; Urticaria 2%-3% anaphylaxis 0.01%-0.1% |
| HFA=hydrofluroalkaline-134a; DPI=dry powder inhaler; MDI=pressurized metered dose inhaler; BDP=beclomethasone dipropionate; SC=subcutaneous; LFT=liver function tests; CHF=congestive heart failure; N/A=not available. | ||||
|
Copyright
2004 The Cleveland Clinic Foundation
|